DCPH News and Press, Deciphera Pharmaceuticals Inc.

2024-06-11 10:22:44 ET More on Deciphera Pharmaceuticals Diving Into Deciphera Pharmaceuticals Deciphera Pharmaceuticals ticks higher as HSR waiting period for ONO sale expires ONO to acquire Deciphera Pharmaceuticals in $2.4B deal Seeking Alpha’s Quan...

– MOTION Phase 3 Data Demonstrate Robust Efficacy, Clinically Meaningful Improvements in Quality-of-Life Measures, and Well-Tolerated Safety Profile, Positioning Vimseltinib as Potential New TGCT Treatment – – Company Expects to Submit a New Drug Application (NDA) in ...

2024-05-22 13:50:44 ET More on Deciphera Pharmaceuticals Diving Into Deciphera Pharmaceuticals ONO to acquire Deciphera Pharmaceuticals in $2.4B deal Deciphera stock soars after Ono Pharmaceutical’s $2.4B buyout deal Seeking Alpha’s Quant Rating...

2024-05-10 13:54:15 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Deciphera Pharmaceuticals (NASDAQ: DCPH ) just reported results for the first quarter of 2024. Deciphera Pharmaceuticals reported earnings per share of -52 cents. This was...

Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...

2024-05-05 06:27:47 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Read the full article on Seeking Alpha For further details see: Wall Street Breakfast: The Week Ahead

2024-05-03 15:00:00 ET More on the markets My Current View Of The Market: May 2024 Edition (Technical Analysis) SPY: The 'Value' From Equities Is Historically Low SPY: The Setup Looks Extremely Bearish 'Sell in May and go away': Does it apply in 2024? ...

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

2024-04-30 15:03:39 ET Summary The biotech sector has experienced significant volatility but has returned around the same as the risk-free return from the 10-Year Treasury over the past year. There are two key items that will determine the direction of small and midcap biotech sto...

2024-04-30 08:07:36 ET More on Ono Pharmaceutical Co., Ltd. Historical earnings data for Ono Pharmaceutical Co., Ltd. Financial information for Ono Pharmaceutical Co., Ltd. Read the full article on Seeking Alpha For further details see: ONO to acquire Dec...